Triveni Bio Launches With $92 Million Series A Financing To Advance Genetics-Informed Precision Medicines For The Treatment Of Immunological And Inflammatory (I&I) Disorders
Amount Raised
$92 Million
Round Type
Series A
WalthamBiotechnologyHealth CareInvestors
Description
Triveni Bio Inc., a biotech company pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of I&I disorders, today announced a $92 million series A financing co-led by Atlas Venture and Cormorant Asset Management, with participation from OrbiMed, the private equity business of Viking Global Investors, Invus, Polaris Partners, Alexandria Venture Investments, and other investors.
Quick answer
Triveni Bio raised $92 Million in a Series A round, dated October 26, 2023. Investors: Alexandria Venture Investments, Polaris Partners, Invus, Viking Global Investors, Orbi Med, Cormorant Asset Management and Atlas Venture. Triveni Bio is based in Waltham, Massachusetts, United States.
- How much did Triveni Bio raise?
- Triveni Bio raised $92 Million in a Series A round on October 26, 2023.
- Who invested in Triveni Bio?
- Alexandria Venture Investments, Polaris Partners, Invus, Viking Global Investors, Orbi Med, Cormorant Asset Management and Atlas Venture are named as investors in this round.
- What does Triveni Bio do?
- Triveni Bio is a biotech company pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of I&I disorders.
- Where is Triveni Bio based and how big is it?
- Triveni Bio is based in Waltham, Massachusetts, United States.
- Who are the decision-makers at Triveni Bio?
- Fundz holds 2 contacts at Triveni Bio, including the Chief Medical Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Triveni Bio that raised within 45 days of this round, from Fundz verified event records.
- Phio Pharmaceuticals raised $533K (Seed) on December 8, 2023.
- Synnovation Therapeutics, Inc. raised $70M on December 8, 2023.
- Os Therapies raised $700K on December 8, 2023.
- AdvanCell raised $5M on December 7, 2023.
- Ratio Therapeutics raised $51M on December 7, 2023.
- Intrommune Therapeutics, Inc. raised $210K (Seed) on December 6, 2023.
Who to call at Triveni Bio, and when
A new round usually means Triveni Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Triveni Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Triveni Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Triveni Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Triveni Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansTriveni Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.